Researchers investigated the effects of α-Hederin, a natural compound, on cisplatin resistance in non-small cell lung cancer (NSCLC). Understanding this interaction is crucial for improving chemotherapy outcomes in NSCLC patients.
Researchers investigated the potential anti-esophageal cancer effects of Gynostemma pentaphyllum Thunb. Makino. Understanding its active components and mechanisms can lead to improved treatment options for esophageal cancer.
Researchers used nanotechnology to enhance the delivery and effectiveness of potential anti-cancer compounds against ovarian cancer. Computational analysis confirmed their affinity with cancer pathway proteins, while liposomal technology improved drug delivery and uptake. This approach has the potential to revolutionize ovarian cancer treatment.
Iraqi chloroform leaf extract was investigated for its ability to protect against DEN-induced hepatocellular carcinoma (HCC) in male Wistar Albino rats. This research is relevant for finding potential treatments for HCC.
This paper suggests using mistletoe extract as a potential treatment for dogs with cancer. It contains compounds that can inhibit cancer cell growth and stimulate the immune system, improving well-being. Its low side effect profile makes it worth considering.
Embelin from Embelia plants inhibits cancer cell growth via multiple mechanisms, making it a promising anticancer agent supported by scientific literature. Consider its potential for your lab's research on cancer treatment.
Researchers investigated the neuroprotective effects of a formulation containing Bacopa monnieri leaves, Nigella sativa, and Curcuma longa rhizome seeds. This formulation may help protect against oxidative stress and cell death induced by diclofenac, a common anti-inflammatory drug.
Triptolide (TPL) from Tripterygium wilfordii inhibits colorectal cancer (CRC) cell growth and invasion. It promotes cell death and reduces the levels of MMP-2 and MMP-9. The mechanism involves inhibition of Nrf2 signaling.